Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $118,945 | 68 | 68.3% |
| Consulting Fee | $31,822 | 9 | 18.3% |
| Food and Beverage | $13,996 | 779 | 8.0% |
| Travel and Lodging | $8,968 | 93 | 5.1% |
| Education | $260.82 | 25 | 0.1% |
| Gift | $227.43 | 10 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $61,733 | 73 | $0 (2020) |
| ABBVIE INC. | $36,467 | 142 | $0 (2024) |
| Biogen, Inc. | $29,695 | 100 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $17,683 | 80 | $0 (2024) |
| Allergan, Inc. | $8,580 | 49 | $0 (2021) |
| Acorda Therapeutics, Inc | $5,485 | 15 | $0 (2019) |
| Amgen Inc. | $4,993 | 16 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $2,554 | 211 | $0 (2024) |
| Genentech USA, Inc. | $2,465 | 17 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $587.41 | 45 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,212 | 138 | ABBVIE INC. ($5,651) |
| 2023 | $9,764 | 95 | AbbVie Inc. ($9,115) |
| 2022 | $14,519 | 77 | ABBVIE INC. ($13,849) |
| 2021 | $10,043 | 78 | AbbVie Inc. ($7,764) |
| 2020 | $14,012 | 67 | GENZYME CORPORATION ($7,044) |
| 2019 | $23,015 | 121 | GENZYME CORPORATION ($21,546) |
| 2018 | $36,086 | 170 | GENZYME CORPORATION ($16,886) |
| 2017 | $59,568 | 238 | GENZYME CORPORATION ($16,258) |
All Payment Transactions
984 individual payment records from CMS Open Payments — Page 1 of 40
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug), VYVGART | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Neurology | ||||||
| 12/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.63 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/17/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 12/16/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Education | In-kind items and services | $8.35 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/13/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Neuroscience | ||||||
| 12/13/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $8.48 | General |
| Category: Neurology | ||||||
| 12/12/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: Neurology | ||||||
| 12/10/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.42 | General |
| Category: NEUROLOGY | ||||||
| 12/06/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Neurology | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: Neurology | ||||||
| 11/26/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/22/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $10.03 | General |
| Category: Neuroscience | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $10.99 | General |
| Category: Neurology | ||||||
| 11/08/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Neurology | ||||||
| 11/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.94 | General |
| Category: NEUROSCIENCE | ||||||
| 11/02/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: Neuroscience | ||||||
| 11/02/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.16 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug), VYVGART | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Neurology | ||||||
| 10/28/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $1.71 | General |
| Category: Neurology | ||||||
| 10/26/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.60 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Neurology | ||||||
| 10/14/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 3,288 | 14,097 | $1.2M | $520,531 |
| 2022 | 30 | 3,258 | 9,132 | $1.0M | $471,326 |
| 2021 | 22 | 2,680 | 16,101 | $951,110 | $459,297 |
| 2020 | 23 | 1,867 | 8,860 | $542,996 | $279,768 |
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 618 | 997 | $160,565 | $102,257 | 63.7% |
| 93890 | Ultrasound of within the brain blood flow following medication | Office | 2023 | 366 | 367 | $165,510 | $75,526 | 45.6% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2023 | 359 | 360 | $210,819 | $72,288 | 34.3% |
| 93892 | Ultrasound of within the brain blood flow for blood clots | Office | 2023 | 363 | 364 | $146,020 | $52,748 | 36.1% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 365 | 367 | $165,790 | $52,377 | 31.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 21 | 10,300 | $92,700 | $51,062 | 55.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 251 | 251 | $63,350 | $33,983 | 53.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 375 | 466 | $53,722 | $32,636 | 60.7% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 21 | 54 | $16,440 | $6,635 | 40.4% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 22 | 22 | $7,700 | $5,162 | 67.0% |
| 92546 | Test for abnormal eye movement using a rotating chair | Office | 2023 | 44 | 44 | $7,770 | $5,017 | 64.6% |
| 92540 | Evaluation and testing for balance with recording | Office | 2023 | 44 | 44 | $9,990 | $4,232 | 42.4% |
| 93930 | Ultrasound of arm arteries or artery grafts | Office | 2023 | 23 | 23 | $10,350 | $4,023 | 38.9% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 34 | 35 | $9,050 | $3,534 | 39.0% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2023 | 83 | 84 | $8,480 | $3,106 | 36.6% |
| 96137 | Administration of psychological or neuropsychological test, each additional 30 minutes | Office | 2023 | 83 | 84 | $6,360 | $2,882 | 45.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 18 | $4,050 | $2,750 | 67.9% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 12 | 12 | $5,400 | $2,319 | 42.9% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 12 | 12 | $2,100 | $1,685 | 80.2% |
| 93882 | Ultrasound of one side of head and neck blood flow | Office | 2023 | 17 | 17 | $5,100 | $1,585 | 31.1% |
| 92537 | Test to assess balance during warm and cool irrigation in both ears | Office | 2023 | 38 | 38 | $2,688 | $1,386 | 51.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 14 | 14 | $1,610 | $1,043 | 64.8% |
| 92547 | Use of electrodes during balance testing | Office | 2023 | 44 | 44 | $888.00 | $454.08 | 51.1% |
| 97750 | Test or measurement for functional capacity, each 15 minutes | Office | 2023 | 14 | 14 | $840.00 | $429.63 | 51.1% |
| 95992 | Repositioning exercises of head for treatment of dizziness, each day | Office | 2023 | 11 | 12 | $1,200 | $426.03 | 35.5% |
About Dr. Roger Behar, M.D
Dr. Roger Behar, M.D is a Neurology healthcare provider based in Somerset, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386685303.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roger Behar, M.D has received a total of $174,219 in payments from pharmaceutical and medical device companies, with $7,212 received in 2024. These payments were reported across 984 transactions from 60 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($118,945).
As a Medicare-enrolled provider, Behar has provided services to 11,093 Medicare beneficiaries, totaling 48,190 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Somerset, NJ
- Active Since 06/09/2006
- Last Updated 08/30/2012
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1386685303
Products in Payments
- AUBAGIO (Drug) $61,694
- UBRELVY (Drug) $30,009
- TECFIDERA (Drug) $22,653
- QULIPTA (Drug) $14,606
- COPAXONE (Drug) $11,553
- TYSABRI (Biological) $6,922
- SD809-TD (Drug) $5,696
- AMPYRA (Drug) $5,462
- Non-Covered Product (Drug) $2,246
- KESIMPTA (Drug) $1,312
- NUPLAZID (Drug) $587.41
- GILENYA (Drug) $392.89
- Leqembi (Drug) $371.95
- MAYZENT (Drug) $351.23
- AIMOVIG (Biological) $323.22
- NUEDEXTA (Drug) $314.80
- TROKENDI XR (Drug) $252.94
- Equetro (Drug) $228.27
- BOTOX (Biological) $183.34
- OCREVUS (Biological) $165.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Somerset
Dr. Anthony Giampolo, M.d, M.D
Neurology — Payments: $293,165
Dr. Seema Dixit, D.o, D.O
Neurology — Payments: $81,509
Stephanus Busono, Md, MD
Neurology — Payments: $35,040
Devin Friedlander, M.d, M.D
Neurology — Payments: $18,891
Colleen Schulte, Apn, APN
Neurology — Payments: $12,721
Dr. Joshua Hersh, M.d, M.D
Neurology — Payments: $8,292